Cargando…
The Anti-Amyloid-β and Neuroprotective Properties of a Novel Tricyclic Pyrone Molecule
There is an urgent unmet need for new therapeutics for Alzheimer’s disease (AD), the most common cause of dementia in the elderly. Therapeutic approaches targeting amyloid-β (Aβ) and its downstream toxicities have become major strategies in AD drug development. We have taken a rational design approa...
Autores principales: | Maezawa, Izumi, Zou, Bende, Di Lucente, Jacopo, Cao, William S., Pascual, Conrado, Weerasekara, Sahani, Zhang, Man, Xie, Xinmin Simon, Hua, Duy H., Jin, Lee-Way |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5438482/ https://www.ncbi.nlm.nih.gov/pubmed/28482635 http://dx.doi.org/10.3233/JAD-161175 |
Ejemplares similares
-
Tricyclic pyrone compounds prevent aggregation and reverse cellular phenotypes caused by expression of mutant huntingtin protein in striatal neurons
por: Trushina, Eugenia, et al.
Publicado: (2009) -
A Selective Intramolecular
5-exo-dig
or 6-endo-dig Cyclization en Route to 2-Furanone
or 2-Pyrone Containing Tricyclic Scaffolds
por: Bengtsson, Christoffer, et al.
Publicado: (2011) -
Biosynthesis of α-pyrones
por: Schäberle, Till F
Publicado: (2016) -
A Bifunctional Anti-Amyloid Blocks Oxidative Stress and the Accumulation of Intraneuronal Amyloid-Beta
por: Hilt, Silvia, et al.
Publicado: (2018) -
Repurposing the KCa3.1 inhibitor senicapoc for Alzheimer's disease
por: Jin, Lee‐Way, et al.
Publicado: (2019)